使用DoseOptimal框架优化脏移植后的塔克罗利斯剂量:分析CYP3A5遗传变异的解释性
Chintal Upendra Raval1, Ashwin Makwana1, Samir Patel2
1U & P U Patel Department of Computer Engineering, Chandubhai S. Patel Institute of Technology, Charotar University of Science and Technology, CHARUSAT - Campus, Changa, Anand, Gujarat, 388421, India.
International journal of clinical pharmacy
|March 21, 2025
概括
这项研究使用DoseOptimal框架优化了对移植患者的塔克罗利莫斯剂量,并结合了CYP3A5遗传变异,以提高精度和患者的治疗结果.
科学领域:
- 药物基因组学 药物基因组学
- 移植医学 移植医学 移植医学
- 医疗保健中的机器学习
背景情况:
- 最佳的塔克罗利斯剂量对于平衡移植患者的疗效和安全至关重要.
- 由于CYP3A5的基因变异和患者的变异性,因此需要个性化剂量策略.
- 精准医学方法对于量身定制塔克罗利木斯治疗至关重要.
研究的目的:
- 为了优化移植患者的塔克罗利斯剂量预测.
- 为了提高准确性,将CYP3A5遗传多态性整合到DoseOptimal框架中.
- 为了提高tacrolimus剂量决策的可解释性和可靠性.
主要方法:
- 通过整合高性能机器学习模型开发了DoseOptimal框架.
- 纳入了SHapley添加式解释 (SHAP) 和决策树洞察力,以提供可解释性.
- 利用了来自1045名患者的临床,人口和CYP3A5遗传数据.
主要成果:
- 剂量最佳框架实现了高性能 (R2=0.884培训,R2=0.830测试).
- 平均绝对误差 (MAE) 很低 (0.40 mg/天训练,0.41 mg/天测试).
- 在87.6%的试验队列中,可以实现准确的剂量预测,最低限度的低估/高估.
结论:
- 开发的框架提供基于精密药物的塔克罗利斯剂量解决方案.
- 量身定制剂量以满足个体遗传特征,可以最大限度地减少错误.
- 改进的剂量策略改善了移植患者的治疗结果.
相关概念视频
01:11Renal Failure: Dose Adjustments
51
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
51
01:17Factors Affecting Renal Clearance: Renal Impairment
45
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
45
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
152
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
152
01:15Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
01:15Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
01:12Analysis of Population Pharmacokinetic Data
206
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
206